NCT06739343 is a NA clinical trial of PHACO-Trabeculectomy in Cataract, sponsored by Emeka John Dingwoke.

Who is sponsoring NCT06739343?

NCT06739343 is sponsored by Emeka John Dingwoke.

What drugs are being tested in NCT06739343?

Interventions in NCT06739343: PHACO-Trabeculectomy, MSICS-Trabeculectomy.

What condition does NCT06739343 study?

NCT06739343 studies Cataract, Glaucoma.

Is NCT06739343 still recruiting?

NCT06739343 is currently completed. Last updated 18 December 2024.

Last reviewed 2024-12-18 · How we verify

NCT06739343

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Phaco-Trabeculectomy and MSICS-Trab in Cataract and Glaucoma Patients

Completed NA Last updated 18 December 2024

What this trial tests

NA trial testing PHACO-Trabeculectomy in Cataract in 122 participants. Completed in 30 September 2024.

Timeline

21 September 2022

Primary endpoint
30 September 2024

30 September 2024

Quick facts

Lead sponsor	Emeka John Dingwoke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	122
Start date	21 September 2022
Primary completion	30 September 2024
Estimated completion	30 September 2024
Sites	1 location across Nigeria

Drugs / interventions tested

PHACO-Trabeculectomy
MSICS-Trabeculectomy

Conditions studied

Cataract — all drugs for Cataract →
Glaucoma — all drugs for Glaucoma →

Sponsor

Emeka John Dingwoke

Who can join

18 and older, any sex, with Cataract or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional study is to compare the outcomes of two surgical techniques, Phaco-Trabeculectomy and Manual Small Incision Cataract Surgery (MSICS) with Trabeculectomy, in patients with coexisting cataract and glaucoma at ECWA Eye Hospital, Kano, Nigeria. The study aims to evaluate which technique offers better intraocular pressure (IOP) control, visual acuity improvement, and complication rates postoperatively. The main questions the study seeks to answer are: Does Phaco-Trabeculectomy provide superior IOP control compared to MSICS-Trabeculectomy in patients with coexisting cataract and glaucoma? Which technique is associated with fewer postoperative complications? How do the visual outcomes compare between the two techniques? Participants will be randomly assigned to undergo one of the two surgical techniques based on a predefined protocol. Data will be collected on intraoperative and postoperative parameters, including IOP, visual acuity, and the incidence of complications, with follow-ups extending over a 12-month period. This study aims to provide evidence to guide clinicians in selecting the most effective and safe surgical approach for managing patients with cataract and glaucoma in resource-limited settings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Phaco-trabeculectomy versus MSICS-trabeculectomy for coexisting cataract and glaucoma: visual and IOP outcomes from a randomized trial in Nigeria.
Munaje MI, Aribaba OT, Atima MO, Idakwo U, et al · · 2025 · PMID 41194003 · DOI 10.1186/s12886-025-04482-1

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06739343 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emeka John Dingwoke
Last refreshed: 18 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06739343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing